Schedule 13G ownership disclosure

AnPac Bio-Medical Science Co., Ltd.

Security class unavailable

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,212,700
Percent of class
10.0600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-21-008420
Form type
SC 13G
Filer
Fresh2 Group Ltd
CIK
CIK 1786511
Filed
Feb 11, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub